Merus NV (MRUS)
96.66
-0.11
(-0.11%)
USD |
NASDAQ |
Dec 11, 16:00
96.63
-0.03
(-0.03%)
After-Hours: 18:10
Merus EPS Diluted (Quarterly): -1.262 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Genmab A/S | 0.6431 |
| uniQure NV | -1.376 |
| ProQR Therapeutics NV | -0.1221 |
| argenx SE | -- |
| Pharming Group NV | 0.109 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -95.52M |
| Revenue (Quarterly) | 12.15M |
| Total Expenses (Quarterly) | 107.67M |
| Enterprise Value | 6.716B |
| Gross Profit Margin (Quarterly) | 94.71% |
| Profit Margin (Quarterly) | -786.2% |
| Earnings Yield | -5.52% |
| Normalized Earnings Yield | -5.519 |